Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 7,050 KRW
Change Today +100.00 / 1.44%
Volume 1.1M
As of 2:29 AM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

jw shinyak corp (067290) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/6/15 - 12,200
52 Week Low
12/18/14 - 4,417
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for JW SHINYAK CORP (067290)

Related News

No related news articles were found.

jw shinyak corp (067290) Related Businessweek News

No Related Businessweek News Found

jw shinyak corp (067290) Details

JW Shinyak Corporation, a pharmaceutical company, develops, produces, and supplies medicines and medical supplies in South Korea. The company offers cardiovascular, gastrointestinal, urinary, anti fungal, anti viral, respiratory, steroid hormone, and anti obesity products; and NSAIDs, antibiotics, antihistamines, antitussives and expectorants, eye drops, and other products, as well as products in the areas of dermatology, pediatrics, otolaryngology, etc. It also provides drugs for prostate cancer treatment, liver cancer treatment, rheumatoid arthritis treatment, etc. JW Shinyak Corporation is based in Seoul, South Korea.

jw shinyak corp (067290) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jw shinyak corp (067290) Key Developments

JW Shinyak Corporation, Annual General Meeting, Mar 20, 2015

JW Shinyak Corporation, Annual General Meeting, Mar 20, 2015., at 08:30 Korea Standard Time. Location: Seocho-gu, Seoul South Ring Road 2477 (dong). Agenda: To consider consolidated financial statement for the year ended December 31, 2014; to consider appointment of directors; to consider directors remuneration; and to consider audit remuneration.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
067290:KS 7,050.00 KRW +100.00

067290 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 067290.
View Industry Companies

Industry Analysis


Industry Average

Valuation 067290 Industry Range
Price/Earnings 100.0x
Price/Sales 3.4x
Price/Book 6.0x
Price/Cash Flow 100.8x
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JW SHINYAK CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at